Keywords: currency, impact, lifts, smithkline, beecham, first, quarter
Currency impact lifts SmithKline Beecham
Article | 20 April 1999
For the first quarter of 1999, total sales at SmithKline Beecham reachedL2.09 billion ($3.36 billion, a rise of 11% (or 10% excluding currency factors)> ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
